Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan
Open Access
- 7 December 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (24) , 5732
Abstract
Background: Previously, our cross-sectional observational study in Japan revealed high (68%) discordance within treatment goals between psoriasis patients and their physicians. Objective: This secondary analysis aimed to determine whether patient and physician users of biologics have higher treatment goals than users of non-biologics. Methods: A survey for both patients and physicians on background characteristics, disease severity, treatment goals, treatment satisfaction, and health-related quality of life was conducted at 54 sites. Association between treatment goals and biologic/non-biologic users was assessed using ordinal logistic regression models. Results: In total, 449 patient-physician pairs agreed to participate; 425 completed the survey and were analyzed. More biologic users than non-biologic users reported complete clearance (Psoriasis Area and Severity Index 100) as a treatment goal (patient-reported: 23.6% vs. 16.1%; physician-reported: 26.9% vs. 2.2%). Biologic users were significantly associated with higher treatment goals than non-biologic users (patient-reported: 1.8 (1.15–2.87) (odds ratio (9 5% CI)), p = 0.01; physician-reported: 11.0 (5.72–21.01), p < 0.01). Among biologic users, higher treatment goals were associated with higher treatment satisfaction (patient- and physician-rated); lower treatment goals were associated with back lesions and increasing patient age (patient-rated) and higher disease severity (physician-rated). Conclusion: Use of biologics among patients with psoriasis was associated with higher treatment goals. Further use of biologics contributed to treatment satisfaction. Appropriate treatment goals that are shared among patients and their physicians may improve treatment outcomes.Keywords
This publication has 22 references indexed in Scilit:
- Psychometric properties of the Itch Numeric Rating Scale in patients with moderate‐to‐severe plaque psoriasisBritish Journal of Dermatology, 2016
- A patient‐centred approach to biological treatment decision making for psoriasis: an expert consensusJournal of the European Academy of Dermatology and Venereology, 2015
- Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims databaseBMJ Open, 2015
- Treatment goals in psoriasis routine careArchives of Dermatological Research, 2014
- Japanese guidance for use of biologics for psoriasis (the 2013 version)The Journal of Dermatology, 2013
- Low‐dose, short‐term ciclosporin (Neoral®) therapy is effective in improving patients’ quality of life as assessed by Skindex‐16 and GHQ‐28 in mild to severe psoriasis patientsThe Journal of Dermatology, 2010
- Definition of treatment goals for moderate to severe psoriasis: a European consensusArchives of Dermatological Research, 2010
- Current severe psoriasis and the Rule of TensBritish Journal of Dermatology, 2005
- Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth and Quality of Life Outcomes, 2004
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994